Filters
New
Hikma celebrates 20 years on the London Stock Exchange
Story, Corporate
New
Strategic priorities in Hikma Pharmaceuticals R&D: Q&A with Hafrun Fridriksdottir, President Rx and R&D
Insight, Corporate
New
Hikma signs an exclusive agreement with DGI Group to bring Claritag® to the MENA region
Press Release, Business Development
New
Hikma confirms 2025 guidance and updates medium-term growth outlook
Press Release, Financial Results
Hikma Pharmaceuticals announces the launch of STARJEMZA™ (ustekinumab-hmny) Injection, a biosimilar referencing STELARA®...
Press Release, Product
New
Hikma R&D. Innovating Formulation Development. Meet Razan Alsawwaf
Story, Life at Hikma
New
Supporting Breast Cancer Awareness Month at Hikma
Story, Responsibility
Hikma R&D. Innovating analytical development. Meet Edvin Brusač
Story, Life at Hikma
Hikma R&D. Innovating formulation development. Meet Anas Abdull-kareem Younues
Story, Life at Hikma
Hikma and Celltrion strengthen partnership to expand biosimilar access in MENA
Press Release, Business Development
Inspiring women of Hikma - Meet Christine Schneider, General Manager, Hikma Germany
Story, Life at Hikma
Driving pharmaceutical excellence and growth in Pavia: A Q&A with Roberto Gagliano, General Manager, Hikma Italia
Insight, Life at Hikma
Hikma and Richter receive FDA approval for denosumab biosimilars EnobyTM (denosumab- qbde) and XtrenboTM (denosumab- qbd...
Press Release, Product
Hikma R&D Innovating formulation development. Meet Helena Sremec
Story, Life at Hikma
Inspiring women of Hikma. Meet Jaclyn Bachman, Associate Director Validations & Metrology, Cherry Hill, US
Story, Life at Hikma